12/03/2024
8:30 PM | Aytu BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:36 PM | Aytu BioPharma (Subject)
Stonepine Capital Management, LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
4:20 PM | Aytu BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:05 PM | Aytu BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:08 PM | Aytu BioPharma (Issuer)
Selhorn Ryan J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/08/2024
7:44 PM | Aytu BioPharma (Issuer)
DOCKERY CARL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
7:27 PM | Aytu BioPharma (Issuer)
JAIN ABHINAV (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
7:34 PM | Aytu BioPharma (Issuer)
Donofrio John Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
6:49 PM | Aytu BioPharma (Issuer)
Disbrow Jarrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
6:55 PM | Aytu BioPharma (Issuer)
Disbrow Joshua R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
6:32 PM | Aytu BioPharma (Issuer)
LIU VIVIAN H (Reporting)
| Form 4/A | |
Get the Latest News and Ratings for AYTU and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter. |
11/08/2024
6:37 PM | Aytu BioPharma (Issuer)
LIU VIVIAN H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
6:23 PM | Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
11:15 PM | Aytu BioPharma (Filer)
| Form EFFECT | |
10/11/2024
4:01 PM | Aytu BioPharma (Filer)
| Form S-3/A | |
10/02/2024
4:18 PM | Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
7:00 AM | Aytu BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
3:29 PM | Aytu BioPharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/26/2024
3:32 PM | Aytu BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
7:00 AM | Aytu BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
4:20 PM | Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:36 PM | Aytu BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
4:09 PM | Aytu BioPharma (Issuer)
Harkey Wilmot B. (Reporting)
Mack Daniel (Reporting)
Nantahala Capital Management, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:30 PM | Aytu BioPharma (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13D/A | |
06/18/2024
7:05 AM | Aytu BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:44 PM | Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
